FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP is a medicine that mixes an enzyme called Fungal Diastase and another enzyme called Pepsin with a liver‑supporting syrup. Making this liquid needs control of enzyme stability, pH level, thickness, flavour microbial safety and how the ingredients fit together. Because Fungal Diastase and Pepsin are enzymes the process must use steps and storage conditions. Pharmaceutical companies that grow a PCD Pharma Franchise can add FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP to a range of medicines keeping clear quality rules and good packaging.
The product contains Fungal Diastase 50 mg and Pepsin 10 mg with the chosen liver syrup. The final medicine may also include pharmaceutical‑grade carriers, sweeteners, flavourings, thickening agents, stabilisers and preservatives depending on the final design.
The syrup must give an environment that keeps the enzymes evenly spread. Enzyme stability can change with pH, heat and the surrounding mix so these factors are checked in development.
Compatibility tests can be run between Fungal Diastase, Pepsin and the chosen excipients. Extra checks may be needed if the liver syrup has plant, nutrition or drug ingredients because each one can affect the whole mix.
The goal is to make a liquid that has the right thickness looks good has a pleasant taste and stays uniform while keeping the active parts at their required amounts.
Choosing the base is a key step in making FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP. The base must. Spread the components well and stay physically stable.
Pharmaceutical‑grade water can be the carrier, with other compatible liquid parts added. Sweeteners and thickening agents can be mixed in based on the design. When the liver syrup has ingredients a compatibility test can spot possible reactions that might change colour, smell, pH, thickness or long‑term stability.
The final pH must be kept correct because enzyme products have stability ranges. Trials help find a pH that does not hurt other parts.
Flavourings can be chosen to match the syrup and the desired taste. The finished base should give the feel and look for every batch.
Production starts by checking all materials to match set quality rules. The liquid base and other excipients are made in a vessel under controlled conditions.
Sweeteners, thickening agents and other soluble parts are added following a planned order. If thickening agents are used they must be fully hydrated and spread before moving on.
Fungal Diastase and Pepsin are added at a controlled time that matches their processing needs. Temperature control is very important during this step. The enzymes should not be exposed to bad conditions.
Gentle stirring spreads everything evenly throughout the bulk. The speed and time of mixing are set during development to keep blending and avoid too much air or stress.
If the product contains liver‑syrup ingredients the order of adding them may be tuned separately to ensure full mixing and uniformity.
After the bulk is ready suitable in‑process tests are done before the liquid is filled into containers.
Quality control of FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP checks the finished liquid and its active parts.
Physical tests look at appearance, colour, smell, pH, thickness, density and fill volume. These help show that each product is the same.
For Fungal Diastase and Pepsin the analytical or enzyme‑activity tests are used according to the final spec. The chosen methods must be validated for this purpose.
If the liver syrup has active or nutrition parts each part may need proper identification and quantity testing as per spec.
Microbial safety is crucial for water‑based syrups. Microbiology tests can be. Preservative effectiveness can be checked if preservatives are used.
Uniformity tests confirm that the enzymes and other ingredients stay evenly spread in the bulk. Filling checks also verify that each container gets the volume.
Stability tests show whether FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP keeps its required properties over the shelf life.
These tests watch appearance, pH, thickness, enzyme activity, microbial safety and other key parameters.
If the product has liver‑syrup parts their stability is also examined as part of the overall program.
Changes in colour, settling, smell or thickness give clues about physical stability.
Packaging must protect the liquid during storage and transport.
Pharmaceutical‑grade bottles made from material can be chosen based on the product’s stability profile.
The bottle and cap must seal well. Keep out unwanted environmental factors.
Compatibility checks can evaluate how the syrup reacts with bottle, cap or liner materials.
Stability tests should use the commercial packaging. The data help set storage conditions and expected shelf life.
FUNGAL DIASTASE 50 MG + PEPSIN 10 MG WITH LIVER SYRUP can join a range of medicines, such as enzyme syrups, drops, suspensions and more. Standard specs and good packaging keep the line consistent.
For a PCD Pharma Franchise portfolio the product can be shown with its exact composition, size, maker details, storage info and other approved facts. The label design must match the product and meet regulations.
The development steps include qualifying materials picking the vehicle checking compatibility adding enzymes carefully setting thickness mixing the bulk, testing quality filling and checking stability.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech